Interleukin-6 and procalcitonin - Prognostic and discriminative value of measurements in patients of intensive care unit and after extensive surgery;Interleukina-6 i prokalcytonina - Wartość prognostyczna i dyskryminacyjna oznaczeń u pacjentów oddziału intensywnej terapii i poddanych rozległym zabiegom operacyjnym

Polski Przeglad Kardiologiczny

Volumn 6, Issue 1, 2004, Pages 57-62

  Lipińska Gediga, Małgorzata ^a   Mierzchała, Magdalena ^a   Kübler, Andrzej ^a   Kustrzycki, Wojciech ^b   Pelczar, Marek ^b  

^a Katedra i Klinika Anestezjologii i Intensywnej Terapii AM we Wroc awiu   (United States)

^b Klinika Chirurgii Serca AM we Wroc awiu   (United States)

Author keywords

Interleukin 6 (IL 6); Procalcitonin (PCT); Sepsis; Septic shock

Indexed keywords

EID: 33751030404     PISSN: 15075540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bone R.C.: Sepsis and its complications: the clinical problem. Crit. Care Med., 1994, 22, S8-S11.
2. Rangel-Frausto M.S., Pittet D., Costigan M. i wsp.: The Natural History of the Systemic Inflammatory Response Syndrome (SIRS). JAMA, 1995, 273, 117-123.
3. American College of Chest Physicians-Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and giudelines for the use of innovative therapies in sepsis. Crit. Care Med., 1992, 20, 864-875.
4. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E.: APACHE II: a severity of disease classfication system. Crit. Care Med., 1985, 13, 13-18.
5. Bellomo R.: The Cytokine Network in Critically Ill. Anaesthesia Intensiv. Care, 1992, 20, 288-302.
6. Doughty L.A., Kaplan S.S., Carcillo J.A.: Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit. Care Med., 1996, 24, 1137-1143.
7. Factor-α and interleukin-6 selectively regulate neutrophil function in vitro. J. Surg. Res., 1995, 58, 124-130.
8. Kung A.: Cytokines and hormonal regulations. Curr. Opin. Endocrinol. Diabetes, 1999, 6, 77-83.
9. Kent L.W., Rahemtulla F., Hockett R.D. Jr i wsp.: Effect of lipopolysaccharide and inflammatory cytokines on interleukin-6 production by healthy human gingival fibroblasts. Infect. Immun., 1998, 66, 608-614.
10. Spath-Schwalbe E., Hansen K., Schmidt F. i wsp.: Acute effects of recombinant human IL-6 on endocrine and central nervous sleep functions in health men. J. Clin. Endocrinol. Metab., 1998, 83, 1573-1579.
11. Karzai W., Meier-Hellmann A., Reinhart K.: Procalcitonin-An Indicator of Sepsis. In yearbook of Int Care and Emergency Med. J.L. Vincent (red.). Springer-Verlag, Berlin-Heidelberg-New York 1998, 247-256.
12. Casey L.C., Balk R.A., Bone R.C.: Plasma cytokine and endotoxine levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med., 1993, 119, 771-778.
13. Damas P., Ledoux D., Nys M. i wsp.: Cytokine serum level during severe sepsis in human: IL-6 as a marker of severity. Ann. Surg., 1992, 215, 356-362.
14. Moscovitz H., Shofer F., Mignott H. i wsp.: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit. Care Med., 1994, 22, 1102-1107.
15. Mihara M., Morija Y., Kishimoto T., Ohsugi Y.: Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br. J. Rheumatol., 1995, 34, 321-325.
16. Gebhard F., Pfetsch H., Steinbach G. i wsp.: Is Interleukin-6 an Early Marker of Injury Severity Following Major Trauma in Humans? Arch. Surg., 2000, 135, 291-295.
17. Karzai W., Oberhoffer M., Meier-Hellmann A., Reinhart K.: Procalcitonin - A New Indicator of the Systemic Response to Severe Infections. Infection, 1997, 25, 329-334.
18. Schröder J., Staubach K.-H., Zabel P. i wsp.: Procalcitonin as a marker of severity in septic shock. Langenbecks Arch. Surg., 1999, 384, 33-38.
19. Bohuon C., Assicot M.: Procalcitonin - a new innovative sepsis marker. 3 rd Inernational Congress on the immune consequences of trauma, shock and sepsis: mechanism and therapeutic approaches, Munch 1994.
20. Kretzschmar M., Kruger A., Schirrmeister W.: Procalcitonin following elective partial liver resection-origin from the liver? Acta Anaesthesiol. Scand., 2001, 45, 1162-1167.
21. Silomon M., Bach F., Ecker D. i wsp.: Procalcitonin after extracorporeal circulation. Synthesis in the hepatosplanchnic region. Anaesthesist, 1999, 48, 395-398.
22. Jorgensen P.F., Wang J.E., Solberg R. i wsp.: Procalcitonin does not influence the surface expression of inflammatory receptors on whole blood leukocytes. Int. Care Med., 2001, 27, 430-433.
23. Nylen E.S., Wang K.T., Snider R.H. Jr i wsp.: Mortality is increased by procalcitonin and decreased by antiserum reactive to procalcitonin in experimental sepsis. Crit. Care Med., 1998, 26, 1001-1006.
24. Meisner M., Tschaikowsky K., Hutzler A. i wsp.: Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med., 1998, 24, 680-684.
25. Rau B., Steinbach G., Gaunsauge F. i wsp.: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut, 1997, 41, 832-840.
26. Jansen M., Hendriks T., Vogels M. i wsp.: Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome. Crit. Care Med., 1996, 24, 1196-1202.